What you missed this week on Contemporary OB/GYN®
Vice President Kamala Harris hosted the White House’s first-ever Maternal Health Day of Action Summit on Dec. 7. During the Summit, Harris outlined the Administration’s new initiatives and issued a nationwide call to action for public and private sectors to help improve maternal health outcomes.
COVIDmenses is recruiting participants for a study to examine potential effects of COVID-19 vaccination on menstrual health.
Daré Bioscience announces the US Food and Drug Administration has approved their clindamycin phosphate (Xaciato) vaginal gel for bacterial vaginosis.
Low progesterone levels have been associated with an increased rate of miscarriage.